Arsenal Digital Holdings, Inc. (ADHI)

Orchard Therapeutics Income Statement

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Aug 31, 2011	Nov 30, 2010	Nov 30, 2009	Nov 30, 2008	Nov 30, 2007	Nov 30, 2006
Cost of Revenue	1.87	6.93	1.24	3.04	2.22	0.62
Gross Profit	-1.87	-6.93	-1.24	-3.04	-2.22	-0.62
Selling, General & Admin	0.55	0.79	1.36	1.88	2.08	0.79
Operating Expenses	0.55	0.93	1.88	2.62	5.87	3.28
Operating Income	-2.42	-7.86	-3.12	-5.66	-8.09	-3.9
Interest Expense	-	-0.33	-0.26	-0.06	-0.03	-0.06
Interest & Investment Income	0.08	-	0	-	0.03	0.03
Other Non Operating Income (Expenses)	-0.23	-0.17	-0.05	-0	-0.38	-
EBT Excluding Unusual Items	-2.57	-8.37	-3.43	-5.72	-8.47	-3.93
Asset Writedown	-	-	-	-	-0.36	-
Other Unusual Items	0.87	-	-	-0.28	-2.72	-1.64
Pretax Income	-1.7	-8.37	-3.43	-6	-11.55	-5.57
Earnings From Continuing Operations	-1.7	-8.37	-3.43	-6	-11.55	-5.57
Minority Interest in Earnings	0	0.02	0.01	-0	0.29	-
Net Income	-1.69	-8.34	-3.42	-6	-11.26	-5.57
Net Income to Common	-1.69	-8.34	-3.42	-6	-11.26	-5.57
Shares Outstanding (Basic)	2	2	2	2	2	1
Shares Outstanding (Diluted)	2	2	2	2	2	1
Shares Change (YoY)	4.42%	4.92%	2.99%	19.97%	28.69%	19.96%
EPS (Basic)	-0.69	-3.52	-1.51	-2.74	-6.16	-3.92
EPS (Diluted)	-0.69	-3.52	-1.51	-2.74	-6.16	-3.92
Free Cash Flow	-2.17	-7.12	-2.48	-3.94	-6.09	-1.49
Free Cash Flow Per Share	-0.89	-3.00	-1.10	-1.80	-3.33	-1.05
EBITDA	-2.41	-7.86	-3.1	-5.63	-8.08	-3.9
D&A For EBITDA	0	0	0.02	0.03	0.01	0
EBIT	-2.42	-7.86	-3.12	-5.66	-8.09	-3.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.